Patent · US Active

Anti-angiogenic nanoparticle compositions

US8221794B2 · kind B2 · utility

6Cited by
4References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 3, 2010
Grant dateJul 17, 2012
Priority date
Expiry dateMar 3, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/915
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.